Long-Term Exposure to Traffic-Related Air Pollutants and Cognitive Trajectories in the Cardiovascular Health Study

2016 ◽  
Vol 2016 (1) ◽  
Author(s):  
Erin Semmens* ◽  
Annette Fitzpatrick ◽  
Sun-Young Kim ◽  
Helene Margolis ◽  
Fred Lurmann ◽  
...  
Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Simona Costanzo ◽  
Traci M Bartz ◽  
Giovanni de Gaetano ◽  
Augusto F Di Castelnuovo ◽  
Licia Iacoviello ◽  
...  

Introduction: Alcohol intake has been related with a complex group of associations with brain structure in cross-sectional analyses, but to our knowledge, its prospective relationship with structural brain abnormalities detected by MRI has never been reported. Hypothesis: We hypothesized that consumers of 1-<7 drinks/week would have slower progression of leukoaraiosis (white matter abnormalities) but more rapid progression of brain atrophy than longer-term abstainers. Methods: As part of the Cardiovascular Health Study, 1 996 adults aged ≥65 years underwent MRI scanning in 1991-94 and again in 1997-99, having excluded 120 participants with a history of cerebrovascular disease before the initial scan. Alcohol consumption was assessed at each annual visit by self-reported intake of wine, beer and liquor. A 10-point white matter grade (WMG) and ventricular grade (VG) were assessed in a standardized and blinded manner in both scans; hippocampal and total brain volumes were also quantified on the second scan. We estimated the associations of alcohol intake in categories (as reported closest to the date of initial scan), with MRI findings at follow-up with multinomial ordered logistic regression (WMG ≤ 3 ref and ≥ 4; VG ≤ 3 ref , =4 and ≥5) using inverse probability weighting to account for attrition. Results: We observed a U-shaped association with WMG, with significantly lower risk among participants consuming 1-<7 drinks/week (OR 0.38; 95% CI 0.17-0.82, table) than long-term abstainers (P quadtrend = 0.01). For VG, the association was inverse (P trend = 0.06), with significantly less progression among drinkers of 1-<7 drinks/week than long-term abstainers (OR 0.62; 95% CI 0.40-0.97). We identified no significant associations of alcohol intake with quantitative mean hippocampal or total brain volumes at the second scan. Conclusions: Compared with long-term abstention, consumption of 1-<7 drinks/week of alcohol was generally associated with less progression of leukoaraiosis and some measures of brain atrophy in older adults.


2015 ◽  
Vol 12 (2) ◽  
pp. 170-183 ◽  
Author(s):  
Lewis H. Kuller ◽  
Oscar L. Lopez ◽  
James T. Becker ◽  
Yuefang Chang ◽  
Anne B. Newman

2014 ◽  
Vol 48 (6) ◽  
pp. 706-715 ◽  
Author(s):  
T. B. Grammer ◽  
M. E. Kleber ◽  
G. Silbernagel ◽  
S. Pilz ◽  
H. Scharnagl ◽  
...  

2012 ◽  
Vol 67 (9) ◽  
pp. 970-976 ◽  
Author(s):  
Nancy S. Jenny ◽  
Benjamin French ◽  
Alice M. Arnold ◽  
Elsa S. Strotmeyer ◽  
Mary Cushman ◽  
...  

2011 ◽  
Vol 96 (7) ◽  
pp. 2186-2193 ◽  
Author(s):  
Cassianne Robinson-Cohen ◽  
Ronit Katz ◽  
Andrew N. Hoofnagle ◽  
Jane A. Cauley ◽  
Curt D. Furberg ◽  
...  

2018 ◽  
Vol 56 (4) ◽  
pp. 560-564 ◽  
Author(s):  
Barbara Zulus ◽  
Gerda Grünbacher ◽  
Marcus E. Kleber ◽  
Winfried März ◽  
Wilfried Renner

AbstractBackground:Uridine diphosphate glycosyltransferases 1A1 (UGT1A1) plays an essential role in detoxification and excretion of several endogenous and exogenous compounds. A functional polymorphism in the promoter of theUGT1A1gene (TA repeat insertion,UGT1A1*28, rs3064744) has been associated with reducedUGT1A1enzyme activity. The purpose of the present study was to investigate the role ofUGT1A1genotypes in mortality.Methods:UGT1A1genotypes as well as baseline plasma bilirubin levels were analyzed in participants of the Ludwigshafen Risk and Cardiovascular Health study (n=3316).UGT1A1*28 genotypes were determined on an ABI PRISM 3730 genetic analyzer.Results:As expected,UGT1A1genotypes were associated with baseline bilirubin levels (*1/*1 genotype: 9.1±4.6 µmol/L; *1/*28 genotype: 10.8±5.3; *28/*28: 16.9±9.2; p<0.001). During a median follow-up of 10.4 years, 995 subjects (30.0%) died. In a multivariate regression analysis adjusting for age, sex, smoking, type 2 diabetes, dyslipidemia, alanine aminotransferase (ALT) levels and bilirubin levels, theUGT1A1*28 variant predicted lower overall mortality (hazard ratio [HR], 0.86; 95% confidence interval [CI], 0.78–0.95; p=0.003). Contrary to expected, higher baseline bilirubin levels predicted increased mortality (HR, 1.014; 95% CI, 1.002–1.025; p=0.019).Conclusions:TheUGT1A1*28 gene variant is associated with lower mortality rates. The protective effect of theUGT1A1*28 variant likely includes mechanism other than bilirubin metabolism.


2007 ◽  
Vol 153 (2) ◽  
pp. 245-252 ◽  
Author(s):  
Lawrence Liao ◽  
Kevin J. Anstrom ◽  
John S. Gottdiener ◽  
Paul A. Pappas ◽  
David J. Whellan ◽  
...  

2010 ◽  
Vol 58 (4) ◽  
pp. 696-701 ◽  
Author(s):  
Elsa S. Strotmeyer ◽  
Alice M. Arnold ◽  
Robert M. Boudreau ◽  
Diane G. Ives ◽  
Mary Cushman ◽  
...  

Circulation ◽  
2020 ◽  
Vol 141 (Suppl_1) ◽  
Author(s):  
Jacqueline E Kunzelman ◽  
Rachel M Gabor ◽  
Monica Scrobotovici ◽  
Natalie J Blades ◽  
W T Longstreth ◽  
...  

Objective: We investigated two hypotheses: First, incident CHD, defined as myocardial infarction or definite angina, leads to faster long-term cognitive decline. Second, among those with CHD, treatment with CABG surgery or PCI leads to slower long-term cognitive decline. Methods: The Cardiovascular Health Study is a cohort of US adults aged 65+. Global cognitive ability was assessed annually up to 9 times from 1990 to 1998 with the 100-point Modified Mini-Mental State Examination (3MS). We estimated trajectories of 3MS scores in the absence of stroke, adjusting for demographics, health behaviors, and comorbidities. For hypothesis 1, we compared 3MS trajectory after incident CHD with 3MS trajectory in the absence of CHD, censoring at first receipt of CABG/PCI. For hypothesis 2, among participants with CHD, we compared 3MS trajectory after first receipt of CABG/PCI with 3MS trajectory without CABG/PCI. Results: For hypothesis 1, of 4,122 participants, 398 had incident CHD during a mean of 5.9 years of follow-up. Figure Panel A shows model-predicted mean 3MS trajectories without CHD (blue) and after incident CHD (red) diagnosed at ages 70, 75, 80, or 85. Model-predicted 3MS score declined faster after incident CHD, especially for CHD diagnosed at age 80 or later. For example, after incident CHD at age 85, predicted 5-year decline in mean 3MS score through age 90 was 13.9 points (95% CI: 11.0, 16.7) versus 8.9 points (95% CI: 8.1, 9.7) among those without CHD. For hypothesis 2, of 1,183 participants who had prevalent or incident CHD, 118 had their first CABG/PCI during a mean of 4.1 years of follow-up. Model-predicted 3MS score declined faster after first receipt of CABG/PCI ( Figure Panel B ). Conclusions: Older adults diagnosed with incident CHD had faster average cognitive decline than those without CHD. However, treatment with CABG/PCI did not slow cognitive decline among those with CHD. This finding may be due to adverse effects of CABG/PCI on brain health or CABG/PCI recipients having more severe CHD or more cerebral atherosclerosis.


Sign in / Sign up

Export Citation Format

Share Document